Literature DB >> 28139662

Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience.

S Wong1,2, P Santullo1, J O'Driscoll3, A Jamous4, S P Hirani2, M Saif1.   

Abstract

BACKGROUND: This was a retrospective audit, with the aims being to (1) record the use of antibiotics; (2) establish the prevalence of antibiotic-associated diarrhoea (AAD) and Clostridium difficile-associated diarrhoea (CDAD); and (3) assess if there was any seasonal variation in antibiotic use and incidence of AAD.
METHODS: The study was performed at a single spinal cord injury (SCI) centre in the UK. Data were collected using a standardised questionnaire during October 2014 to June 2015. We define AAD as two or more watery stools of type 5, 6 or 7 (Bristol stool scale) over 24 h.
RESULTS: Three-hundred-and-nineteen adults (mean age: 55.9 years, 29.2% female) with SCI (58.2% tetraplegia; 43.7% complete SCI) were included. Of 70 (21.9%) patients on antibiotics, the top three indications for antibiotics were urinary-tract infections, infected pressure ulcers and other skin infections. Seventeen of 78 (21.8%) developed AAD and three of 319 (0.94%) developed CDAD. AAD was more common in the summer season than in spring, autumn and winter (47.1%, 10.0%, 10.0%, 23.8%, P=0.025). AAD was associated with older adults greater than 65 years (70.6% vs 23.8%, P=0.007). Polypharmacy and the summer season were identified as independent predictors for AAD.
CONCLUSION: This survey found that AAD is common in SCI patients and may be a risk factor for a poorer outcome and increased hospital costs. A multicentre study is underway to establish the incidence and risk factors for AAD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28139662     DOI: 10.1038/sc.2016.193

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  15 in total

1.  Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.

Authors:  L J O'Donnell; J Virjee; K W Heaton
Journal:  BMJ       Date:  1990-02-17

Review 2.  Probiotics and their fermented food products are beneficial for health.

Authors:  S Parvez; K A Malik; S Ah Kang; H-Y Kim
Journal:  J Appl Microbiol       Date:  2006-06       Impact factor: 3.772

Review 3.  Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.

Authors:  Nandini Dendukuri; Vania Costa; Maurice McGregor; James M Brophy
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

Review 4.  Mechanisms and management of antibiotic-associated diarrhea.

Authors:  C Högenauer; H F Hammer; G J Krejs; E C Reisinger
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

Review 5.  Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism.

Authors:  J G Bartlett
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

Review 6.  Update on the changing epidemiology of Clostridium difficile-associated disease.

Authors:  Lynne V McFarland
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-01

7.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.

Authors:  Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

8.  Epidemiology of hospital-acquired infections in veterans with spinal cord injury and disorder.

Authors:  Charlesnika T Evans; Sherri L LaVela; Frances M Weaver; Michael Priebe; Paul Sandford; Pamela Niemiec; Scott Miskevics; Jorge P Parada
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

9.  Seasonal variation in human gut microbiome composition.

Authors:  Emily R Davenport; Orna Mizrahi-Man; Katelyn Michelini; Luis B Barreiro; Carole Ober; Yoav Gilad
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

10.  Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.

Authors:  Jeffrey F Barletta; David A Sclar
Journal:  Crit Care       Date:  2014-12-24       Impact factor: 9.097

View more
  3 in total

1.  A study into the effect of Lactobacillus casei Shirota in preventing antibiotic associated diarrhoea including Clostridioides difficile infection in patients with spinal cord injuries: a multicentre randomised, double-blind, placebo-controlled trial.

Authors:  Samford Wong; Shashivadan P Hirani; Alastair Forbes; Naveen Kumar; Ramaswamy Hariharan; Jean O'Driscoll; Anand Viswanathan; Graham Harvey; Ravi Sekhar; Ali Jamous
Journal:  EClinicalMedicine       Date:  2021-09-11

Review 2.  An update on the human and animal enteric pathogen Clostridium perfringens.

Authors:  Raymond Kiu; Lindsay J Hall
Journal:  Emerg Microbes Infect       Date:  2018-08-06       Impact factor: 7.163

3.  P2X7 Receptor (P2X7R) of Microglia Mediates Neuroinflammation by Regulating (NOD)-Like Receptor Protein 3 (NLRP3) Inflammasome-Dependent Inflammation After Spinal Cord Injury.

Authors:  Xiao Fan; Wei Ma; Yingyu Zhang; Li Zhang
Journal:  Med Sci Monit       Date:  2020-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.